Group 1 - The core viewpoint of the article highlights the recent performance and financial metrics of Meihao Medical (301363), indicating a slight decline in stock price and a mixed financial outlook for the first quarter of 2025 [1][3] - As of July 29, 2025, Meihao Medical's stock closed at 19.0 yuan, down 0.89%, with a turnover rate of 4.85% and a trading volume of 75,700 hands, amounting to a transaction value of 143 million yuan [1] - The company experienced a net outflow of main funds amounting to 13.99 million yuan, representing 9.78% of the transaction value, with significant outflows from large and medium orders [1] Group 2 - For the first quarter of 2025, Meihao Medical reported total operating revenue of 296 million yuan, reflecting a year-on-year growth of 5.05%, while net profit attributable to shareholders decreased by 10.62% to 51.88 million yuan [1] - The company's financial ratios indicate a current ratio of 5.964, a quick ratio of 5.060, and a debt-to-asset ratio of 12.08%, suggesting a strong liquidity position [1] - Meihao Medical, established in 2010 and based in Shenzhen, has a registered capital of 406.66 million yuan and a paid-in capital of 321.16 million yuan [1][2]
美好医疗（301363）7月29日主力资金净流出1399.43万元